1. Home
  2. Neoadjuvant therapy
  Subject:

Neoadjuvant therapy   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Chemotherapy  28 times
Breast cancer  18 times
Lymph node  13 times
Estrogen receptor  9 times
Adjuvant therapy  8 times
Multivariate analysis  7 times
Colorectal cancer  7 times
Stomach cancer  6 times
Adenocarcinoma  6 times
Radiation therapy  5 times
Neu!  5 times
Metastasis  4 times
Magnetic resonance imaging  4 times
Gastrectomy  4 times
Esophageal cancer  4 times
Carcinoma  4 times
Axillary lymph nodes  4 times
Univariate  3 times
Trastuzumab  3 times
TNBC  3 times
Sentinel lymph node  3 times
Progression-free survival  3 times
Netherlands  3 times
Nacionalista Party  3 times
Logistic regression  3 times
Hormone  3 times
Histology  3 times
Esophagectomy  3 times
Disease  3 times
Clinical trial  3 times
Cisplatin  3 times
CT scan  3 times
Biopsy  3 times
Biomarker  3 times
Adipose tissue  3 times
Triple-negative breast cancer  2 times
Regression analysis  2 times
Receiver operating characteristic  2 times
RANKL  2 times
PubMed  2 times
Protein  2 times
Programmed cell death protein 1  2 times
Performance status  2 times
Ovarian cancer  2 times
Nuclear magnetic resonance  2 times
Nivolumab  2 times
Neutropenia  2 times
Micrometastasis  2 times
Lymphovascular invasion  2 times
Lymphadenectomy  2 times
Ligand  2 times
Japan  2 times
Immunohistochemistry  2 times
Gene  2 times
Entropy  2 times
Confidence interval  2 times
Chemotherapy regimen  2 times
Anastomosis  2 times
Adjuvant  2 times
Wilcoxon signed-rank test  1 time
Western blot  1 time
Vertebral column  1 time
Univariate analysis  1 time
Tyrosine kinase  1 time
Tumor hypoxia  1 time
Trachea  1 time
Time point  1 time
Time  1 time
Thrombocytopenia  1 time
Teaching hospital  1 time
Tamoxifen  1 time
Survival analysis  1 time
Surgical margin  1 time
Stomach  1 time
Stoma  1 time
Stent  1 time
Squamous cell carcinoma  1 time
Sport utility vehicle  1 time
Spinal canal  1 time
Soft-tissue sarcoma  1 time
Socioeconomic status  1 time
Serum albumin  1 time
Scopus  1 time
Schistosoma  1 time
Sarcoma  1 time
San Francisco  1 time
STIM  1 time
Romantic Times  1 time
Recurrent laryngeal nerve  1 time
Rate of return  1 time
RNA  1 time
Proteomics  1 time
Proportional hazards model  1 time
Propensity score matching  1 time
Positron emission tomography–magnetic resonance imaging  1 time
Portal vein  1 time
Plasma cell  1 time
Phenotype  1 time
Perineural invasion  1 time
P53  1 time
Osteoprotegerin  1 time
Osteoporosis  1 time
Oophorectomy  1 time
Odds ratio  1 time
Neutrophil  1 time
National Health Service  1 time
Multiple myeloma  1 time
Monoclonal antibody  1 time
Mitsubishi Ki-67  1 time
Messenger RNA  1 time
Medical ultrasound  1 time
Mastectomy  1 time
Mann–Whitney U test  1 time
Magic angle spinning  1 time
MTV  1 time
MSH2  1 time
Lymphadenopathy  1 time
Log-rank test  1 time
Lipid  1 time
Linux.conf.au  1 time
Large intestine  1 time
Lactic acid  1 time
Kaplan–Meier estimator  1 time
Ipilimumab  1 time
Interquartile range  1 time
India  1 time
Incremental cost-effectiveness ratio  1 time
Immunophenotyping  1 time
Immune checkpoint  1 time
Ileostomy  1 time
Hypertrophy  1 time
Human musculoskeletal system  1 time
Hoffmann-La Roche  1 time
HeLa  1 time
Haematoxylin  1 time
Growth factor  1 time
Google Scholar  1 time
Gold standard  1 time
Glycolysis  1 time
Glutathione  1 time
Glucose  1 time
Giant cell  1 time
Fluorouracil  1 time
Final Analysis  1 time
Estrogen receptor alpha  1 time
Estrogen  1 time
Epidural administration  1 time
Eosin  1 time
Endocrine system  1 time
Embryo transfer  1 time
Dysphagia  1 time
Dynamic range  1 time
Doxorubicin  1 time
Diarrhea  1 time
D-dimer  1 time
Cyclophosphamide  1 time
Cyclin-dependent kinase 4  1 time
Countermeasure  1 time
Colostomy  1 time
Coagulation  1 time
Cervical cancer  1 time
Carboplatin  1 time
Cancer immunotherapy  1 time
California  1 time
Cadherin  1 time
C-reactive protein  1 time
Bladder cancer  1 time
Bevacizumab  1 time
Axilla  1 time
Archibald Cox  1 time
Apoptosis  1 time
Antioxidant  1 time
Antibody  1 time
Anorexia nervosa  1 time
Anemia  1 time
Analysis of variance  1 time
Anal canal  1 time
Agonist  1 time
AEC Regent III RT  1 time

Publications tagged with this subject: 50

Note: Top 50 publications shown only. Open an item panel to view more info


1. Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer

2. Chemoradiation and Local Excision for T2N0 Rectal Cancer Offers Equivalent Overall Survival Compared to Standard Resection: a National Cancer Database Analysis

3. Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases

4. Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy

5. Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer

6. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer

7. Preoperative bevacizumab and surgery for colorectal liver metastases: a propensity score analysis

8. Prognostic implication of the primary tumor location in early-stage breast cancer: focus on lower inner zone

9. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

10. Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan

11. What Is New in the Diagnosis and Management of Penile Cancer?

12. Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer

13. UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST)

14. Enhancing accrual to chemotherapy trials for patients with early stage triple-negative breast cancer: a survey of physicians and patients

15. Practical Surgical Techniques for Lymphadenectomy Along the Right Recurrent Laryngeal Nerve During Thoracoscopic Esophagectomy in the Prone Position

16. Endoscopic ultrasonography and computed tomography scanning for preoperative staging of colonic cancer

17. Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

18. Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis

19. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA

20. The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review

21. Early closure of defunctioning stoma increases complications related to stoma closure after concurrent chemoradiotherapy and low anterior resection in patients with rectal cancer

22. Delayed versus immediate surgery following short-course neoadjuvant radiotherapy in resectable (T3N0/N+) rectal cancer

23. A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy

24. Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer

25. Progastrin: a potential predictive marker of liver metastasis in colorectal cancer

26. Change in sonographic brightness can predict pathological response of triple-negative breast cancer to neoadjuvant chemotherapy

27. Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety

28. Bilateral ovarian micrometastatic adenocarcinoma upon prophylactic oophorectomy concurrent with low anterior resection for rectal cancer

29. The Growing Role of CDK4/6 Inhibitors in Treating Hormone Receptor-Positive Advanced Breast Cancer

30. Adjuvant Chemoradiotherapy for Non-Pretreated Gastric Cancer

31. Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer

32. Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients

33. Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer

34. Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands

35. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy

36. Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members

37. Predictive factors for survival in neoadjuvant radiochemotherapy for advanced rectal cancer

38. Prognostic significance of supradiaphragmatic lymph nodes at initial presentation in patients with stage III high-grade serous ovarian cancer

39. Successful video-assisted thoracoscopic surgery in prone position in patients with esophageal cancer and aberrant right subclavian artery: report of three cases

40. Sample size and power determination when limited preliminary information is available

41. The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival

42. Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657)

43. Molecular markers of DNA damage and repair in cervical cancer patients treated with cisplatin neoadjuvant chemotherapy: an exploratory study

44. An objective nodal staging system for breast cancer patients undergoing neoadjuvant systemic treatment

45. Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer

46. Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer

47. Clinical overview of the current state and future applications of positron emission tomography in bone and soft tissue sarcoma

48. Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy

49. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios can Predict Treatment Response to Neoadjuvant Therapy in Esophageal Cancer

50. Neoadjuvant Treatment for Locally Invasive Esophageal Cancer


Questions?

Drop us a message.